Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients

[1]  N. Pavlakis,et al.  High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy , 2010, Clinical Cancer Research.

[2]  X. An,et al.  Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[3]  M. Nishimura,et al.  CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection , 2010, Cancer Immunology, Immunotherapy.

[4]  G. Alí,et al.  Tryptase Mast Cells in Malignant Pleural Mesothelioma as an Independent Favorable Prognostic Factor , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  A. Nicholson,et al.  Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.

[6]  T. Dønnem,et al.  Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[7]  T. Tedder,et al.  Regulatory B cells as inhibitors of immune responses and inflammation , 2008, Immunological reviews.

[8]  M. Tsao,et al.  Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. , 2008, The Journal of thoracic and cardiovascular surgery.

[9]  L. Coussens,et al.  Polarized immune responses differentially regulate cancer development , 2008, Immunological reviews.

[10]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[11]  H. Hammad,et al.  Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses , 2006, European Respiratory Journal.

[12]  L. Coussens,et al.  Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.

[13]  T. Oshikiri,et al.  Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma , 2006, British Journal of Cancer.

[14]  Z. Trajanoski,et al.  Effector memory T cells, early metastasis, and survival in colorectal cancer. , 2005, The New England journal of medicine.

[15]  M. ChB.,et al.  Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer , 2005, Journal of surgical oncology.

[16]  T. Blankenstein.  The role of tumor stroma in the interaction between tumor and immune system. , 2005, Current opinion in immunology.

[17]  Elisabeth Brambilla,et al.  Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .

[18]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[19]  W. Wallace,et al.  No relationship between tumour infiltrating lymphocytes and overall survival is seen in malignant mesothelioma of the pleura. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  A. Scarpa,et al.  Pathology and Genetics , 2010 .

[21]  I. Webster,et al.  Lymphocytic infiltration of pleural mesothelioma and its significance for survival. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[22]  C. Lawton,et al.  Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer , 2012 .

[23]  D. Heitjan,et al.  CCL2 blockade augments cancer immunotherapy. , 2010, Cancer research.

[24]  重松 義紀.  Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers , 2009 .

[25]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[26]  B. Robinson,et al.  Malignant mesothelioma. , 2005, Lancet.

[27]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[28]  W. Richards,et al.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.

[29]  W. Travis,et al.  Histological Classification of Lung and Pleural Tumours , 1999 .